Business Strategy
Maintain high value funded R&D alliances
Leverage the value of multiple development programs: cell lines and drug delivery systems
Expand pipelines of novel vaccine candidates
License early stage product opportunities
Sell late stage product opportunities
Decrease capital market risks by leveraging strategic partners for critical paths: